Tag Archives: IBD

November, 2018

October, 2018

September, 2018

July, 2018

June, 2018

May, 2018

January, 2018

  • 5 January

    Takeda Announces Intention to Acquire Cell Therapy Firm TiGenix

    Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today announced its intention to acquire TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”), an advanced biopharmaceutical company developing novel stem cell therapies for serious medical conditions, and as a result has entered into an offer and support agreement with TiGenix which provides …

October, 2017

  • 19 October

    Celgene Discontinues GED-0301 Inflammatory Bowel Disease Program

    SUMMIT, N.J.–(BUSINESS WIRE)–Celgene Corporation (NASDAQ: CELG) today announced that the GED-0301 (mongersen) phase III REVOLVE trial (CD-002) in Crohn’s disease (CD) and the extension trial (SUSTAIN, CD-004) will discontinue. Celgene has decided to stop the trials following an October recommendation of the Data Monitoring Committee, which assessed overall benefit/risk during …